Terms: = Leukemia AND ZRSR2, URP, 8233, ENSG00000169249, U2AF1RS2, MGC142040, U2AF1L2, U2AF1-RS2, MGC142014
62 results:
1. Biological relevance of alternative splicing in hematologic malignancies.
Szelest M; Giannopoulos K
Mol Med; 2024 May; 30(1):62. PubMed ID: 38760666
[TBL] [Abstract] [Full Text] [Related]
2. A novel t(X;21)(p11.4;q22.12) translocation adds to the role of BCOR and RUNX1 in myelodysplastic syndromes and acute myeloid leukemias.
Mavridou E; Lema Fernandez AG; Nardelli C; Pierini V; Quintini M; Arniani S; Di Giacomo D; Crescenzi B; Matteucci C; Sambani C; Mecucci C
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23235. PubMed ID: 38656651
[TBL] [Abstract] [Full Text] [Related]
3. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
Nagehan P; Sabbir M; Song J; Mohammad H
J Clin Exp Hematop; 2023; 63(3):173-176. PubMed ID: 37766563
[TBL] [Abstract] [Full Text] [Related]
4. [RNA splicing dysregulation in hematological malignancies].
Yoshida M; Yamauchi H; Sakumoto M; Yoshimi A
Rinsho Ketsueki; 2023; 64(7):646-653. PubMed ID: 37544725
[TBL] [Abstract] [Full Text] [Related]
5. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
Senapati J; Urrutia S; Loghavi S; Short NJ; Issa GC; Maiti A; Abbas HA; Daver NG; Pemmaraju N; Pierce S; Chien KS; Sasaki K; Kadia TM; Hammond DE; Borthakur G; Patel K; Ravandi F; Kantarjian HM; Garcia-Manero G; DiNardo CD
Blood; 2023 Nov; 142(19):1647-1657. PubMed ID: 37441846
[TBL] [Abstract] [Full Text] [Related]
6. Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center.
Lian Y; Ti J; Ma L; Wei J; Gao Z
Hematology; 2023 Dec; 28(1):2230738. PubMed ID: 37427790
[No Abstract] [Full Text] [Related]
7. Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia.
Jia W; Guo X; Wei Y; Liu J; Can C; Wang R; Yang X; Ji C; Ma D
Mol Biol Rep; 2023 Aug; 50(8):6601-6610. PubMed ID: 37344641
[TBL] [Abstract] [Full Text] [Related]
8. Updates in molecular genetics of acute myeloid leukemia.
Kurzer JH; Weinberg OK
Semin Diagn Pathol; 2023 May; 40(3):140-151. PubMed ID: 37059636
[TBL] [Abstract] [Full Text] [Related]
9. Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.
Zhang B; Zhang Y; Li Q; Jiang Q; Chu W; Gong H; Li R; Ji H
Pathol Oncol Res; 2022; 28():1610653. PubMed ID: 36567979
[No Abstract] [Full Text] [Related]
10. Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia.
Zack MT; Geissler K
Wien Med Wochenschr; 2023 Feb; 173(1-2):21-26. PubMed ID: 36445600
[TBL] [Abstract] [Full Text] [Related]
11. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.
Song GY; Kim T; Ahn SY; Jung SH; Kim M; Yang DH; Lee JJ; Choi SH; Kim MY; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Park SK; Kim SH; Zhang Z; Ahn JS; Kim HJ; Kim DDH
Bone Marrow Transplant; 2022 Dec; 57(12):1810-1819. PubMed ID: 36151367
[TBL] [Abstract] [Full Text] [Related]
13. Dysregulated minor intron splicing in cancer.
Nishimura K; Yamazaki H; Zang W; Inoue D
Cancer Sci; 2022 Sep; 113(9):2934-2942. PubMed ID: 35766428
[TBL] [Abstract] [Full Text] [Related]
14. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
[TBL] [Abstract] [Full Text] [Related]
15. FGF10/FGF17 as prognostic and drug response markers in acute myeloid leukemia.
Ling Y; Du Q
Curr Res Transl Med; 2022 Jan; 70(1):103316. PubMed ID: 34731724
[TBL] [Abstract] [Full Text] [Related]
16. Sex-Biased
Togami K; Chung SS; Madan V; Booth CAG; Kenyon CM; Cabal-Hierro L; Taylor J; Kim SS; Griffin GK; Ghandi M; Li J; Li YY; Angelot-Delettre F; Biichle S; Seiler M; Buonamici S; Lovitch SB; Louissaint A; Morgan EA; Jardin F; Piccaluga PP; Weinstock DM; Hammerman PS; Yang H; Konopleva M; Pemmaraju N; Garnache-Ottou F; Abdel-Wahab O; Koeffler HP; Lane AA
Cancer Discov; 2022 Feb; 12(2):522-541. PubMed ID: 34615655
[TBL] [Abstract] [Full Text] [Related]
17. The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
Chiereghin C; Travaglino E; Zampini M; Saba E; Saitta C; Riva E; Bersanelli M; Della Porta MG
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440317
[TBL] [Abstract] [Full Text] [Related]
18. Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes.
Kataoka N; Matsumoto E; Masaki S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360561
[TBL] [Abstract] [Full Text] [Related]
19. Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia.
Wu M; Guo ZW; Huang GN; Ye YB
Neoplasma; 2021 Sep; 68(5):1072-1078. PubMed ID: 33998238
[TBL] [Abstract] [Full Text] [Related]
20. Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
Lachowiez CA; Loghavi S; Furudate K; Montalban-Bravo G; Maiti A; Kadia T; Daver N; Borthakur G; Pemmaraju N; Sasaki K; Alvarado Y; Yilmaz M; Short NJ; Chien K; Ohanian M; Pierce S; Patel KP; Jabbour E; Ravandi F; Kantarjian HM; Garcia-Manero G; Takahashi K; Konopleva MY; DiNardo CD
Blood Adv; 2021 Apr; 5(8):2173-2183. PubMed ID: 33885753
[TBL] [Abstract] [Full Text] [Related]
[Next]
